Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia

Most malignant hematological diseases are generally a consequence of acquired mutations or rearrangements in cell replication processes. Acute myeloid leukemia (AML) is a clinically and molecularly heterogeneous disease that results from acquired genetic and epigenetic alterations in hematopoietic p...

Descripción completa

Detalles Bibliográficos
Autores principales: Alarcón-Payer, Carolina, Sánchez Suárez, María Del Mar, Martín Roldán, Alicia, Puerta Puerta, José Manuel, Jiménez Morales, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604625/
https://www.ncbi.nlm.nih.gov/pubmed/36294746
http://dx.doi.org/10.3390/jpm12101607

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9604625/
https://www.ncbi.nlm.nih.gov/pubmed/36294746
http://dx.doi.org/10.3390/jpm12101607

Ejemplares similares